The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis

Peritoneal Dialysis International

Volumn 30, Issue 3, 2010, Pages 343-352

  Yamamoto, Tadashi ^a   Nagasue, Kyoko ^a   Okuno, Senji ^a   Yamakawa, Tomoyuki ^a  

^a OSAKA CITY UNIVERSITY   (Japan)

Author keywords

Encapsulating peritoneal sclerosis; Mesothelial cell area; Peritoneal lavage

Indexed keywords

CREATININE;

ADULT; AGED; ALGORITHM; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSATE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MESOTHELIUM CELL; PATIENT CARE; PATIENT CODING; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEUM LAVAGE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TISSUE INJURY; TREATMENT DURATION; TREATMENT WITHDRAWAL;

ADULT; AGED; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEAL LAVAGE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77957658196     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2008.00273     Document Type: Article

References (28)

1. Nakai S, Masakane I, Akiba T, Shigematsu T, Yamagata K, Watanabe Y, et al. An overview of dialysis treatment in Japan (as of Dec. 31, 2006). J Jpn Soc Dial Ther 2008; 41:1-28.
2. Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis 2004; 44:729-37.
3. Nomoto Y, Kawaguchi Y, Sakai S, Hirano H, Kubo H, Ohira S, et al. Sclerosing encapsulating peritonitis (SEP) in patients on continuous ambulatory peritoneal dialysis-definition, diagnosis and treatment recommendations, 1997 update. J Jpn Soc Dial Ther 1998; 31:303-11.
4. Moriishi M, Kawanishi H, Kawai T, Takahashi S, Hirai T, Shishida M, et al. Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis. Adv Perit Dial 2002; 18:149-53.
5. Nakayama M, Yamamoto H, Ikeda M, Hasegawa T, Kato N, Takahashi H, et al. Risk factors and preventive measures for encapsulating peritoneal sclerosis-Jikei experience 2002. Adv Perit Dial 2002; 18:144-8.
6. Otsuka Y, Nakayama M, Ikeda M, Sherif AM, Yokoyama K, Yamamoto H, et al. Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis. Clin Exp Nephrol 2005; 9:315-19.
7. Szeto CC, Wong TY, Lai KB, Lam CW, Lai KN, Li PK. Dialysate hyaluronan concentration predicts survival but not peritoneal sclerosis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000; 36:609-14.
8. Kawanishi H, Fujimori A, Tsuchida K, Takemoto Y, Tomo T, Minakuchi J, et al. Markers in peritoneal effluent for withdrawal from peritoneal dialysis: multicenter prospective study in Japan. Adv Perit Dial 2005; 21:134-8.
9. Moriishi M, Kawanishi H. Fibrin degradation products are a useful marker for the risk of encapsulating peritoneal sclerosis. Adv Perit Dial 2008; 24:56-9.
10. Gotloib L, Wajsbrot V, Shostak A, Kushnier R. Experimental approach to peritoneal morphology. Perit Dial Int 1994; 14(Suppl 3):S6-11.
11. Gotloib L, Wajsbrot V, Shostak A, Kushnier R. Acute and long-term changes observed in imprints of mouse mesothelium exposed to glucose enriched, lactated, buffered dialysis solutions. Nephron 1995; 70:466-77.
12. Gotloib L, Wajsbrot V, Shostak A, Kushnier R. Population analysis of mesothelium in situ and in vivo exposed to bicarbonate-buffered peritoneal dialysis fluid. Nephron 1996; 73:219-27.
13. Gotloib L, Shostak A, Wajsbrot V, Kushnier R. High glucose induces a hypertrophic, senescent mesothelial cell phenotype after long in vivo exposure. Nephron 1999; 82:164-73.
14. Shostak A, Wajsbrot V, Gotloib L. High glucose accelerates the life cycle of the in vitro exposed mesothelium. Kidney Int 2000; 58:2044-52.
15. Yamamoto T, Izumotani T, Otoshi T, Kim M. Morphological studies of mesothelial cells in CAPD effluent and their clinical significance. Am J Kidney Dis 1998; 32:946-52.
16. Izumotani T, Ishimura E, Yamamoto T, Otoshi T, Okuno S, Inaba M, et al. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis. Nephron 2001; 89:43-9.
17. Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant 1998; 13:154-9.
18. Hoshii S, Honda M. High incidence of encapsulating peritoneal sclerosis in pediatric patients on peritoneal dialysis longer than 10 years. Perit Dial Int 2002; 22:730-1.
19. Di Paolo N, Sacchi G. Atlas of peritoneal histology in normal conditions and during peritoneal dialysis. Perit Dial Int 2000; 20(Suppl 3):S37-63.
20. Kanjanabuch T, Siribamrungwong M, Khunprakant R, Kanjanabuch S, Jeungsmarn P, Achavanuntakul B, et al. Overnight mesothelial cell exfoliation: a magic tool for predicting future ultrafiltration failure in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2008; 28(Suppl 3):S107-13.
21. Slater ND, Cope GH, Raftery AT. Mesothelial hyperplasia in response to peritoneal dialysis fluid: a morphometric study in the rat. Nephron 1991; 58:466-71.
22. Schatz JE, Colgan TJ. Squamous metaplasia of the peritoneum. Arch Pathol Lab Med 1991; 115:397-8.
23. Fernandez de Castro M, Selgas R, Jimenez C, Bajo MA, Martinez V, Romero JR, et al. Cell populations present in the nocturnal peritoneal effluent of patients on continuous ambulatory peritoneal dialysis and their relationship with peritoneal function and incidence of peritonitis. Perit Dial Int 1994; 14:265-70.
24. Selgas R, Fernandez de Castro M, Viguer JM, Burgos E, Bajo MA, Carcamo C, et al. Transformed mesothelial cells in patients on CAPD for medium- to long-term periods. Perit Dial Int 1995; 15:305-11.
25. Yáñez-Mó M, Lara-Pezzi E, Selgas R, Ramírez-Huesca M, Domínguez-Jiménez C, Jiménez-Heffernan JA, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348:403-13.
26. Bozkurt D, Sipahi S, Cetin P, Hur E, Özdemit Ö, Ertilav M, et al. Does immunosuppressive treatment ameliorate morphology changes in encapsulating peritoneal sclerosis? Perit Dial Int 2009; 29(Suppl 2):S206-10.
27. Korte MR, Yo M, Betjes MG, Fieren MW, van Saase JC, Boer WH, et al. Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation. Nephrol Dial Transplant 2007; 22:2412-14.
28. Fieren MW, Betjes MG, Korte MR, Boer WH. Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit Dial Int 2007; 27:619-24.